Clinical usefulness of bone turnover marker concentrations in osteoporosis
- 1 April 2017
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 467, 34-41
- https://doi.org/10.1016/j.cca.2016.06.036
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Age-related reference intervals for bone turnover markers from an Australian reference populationBone, 2013
- IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and childrencclm, 2013
- Reference intervals of bone turnover markers in healthy premenopausal women: Results from a cross-sectional European studyBone, 2012
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2012
- Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patientsNephrology Dialysis Transplantation, 2011
- Reference intervals of biochemical bone turnover markers for Saudi Arabian women: A cross-sectional studyBone, 2010
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United StatesJournal of Bone and Mineral Research, 2009
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal DialysisJournal of Clinical Endocrinology & Metabolism, 2009
- Chronic kidney disease and bone fracture: a growing concernKidney International, 2008
- Establishing a reference range for bone turnover markers in young, healthy womenBone, 2008